DRIO DarioHealth Corp.
Healthcare$7.51-4.45%ClosedMarket Cap: $54.9M
As of 2026-05-26
Valuation
P/E (TTM)
5.83
PEG
0.00
P/B
6.25
P/S
2.71
EV/EBITDA
-1.96
DCF Value
$-6.01
FCF Yield
-44.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
56.5%
Operating Margin
-251.9%
Net Margin
295.9%
ROE
93.2%
ROA
60.7%
ROIC
-56.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $5.6M | 57.3% | $-7.3M | $-8.2M | $— | — |
| Q4 null | $5.2M | 45.3% | $-45.8M | $86.0M | $— | — |
| FY null | $22.4M | 56.6% | $-36.7M | $-41.7M | $— | — |
| Q3 null | $5.0M | 60.2% | $-9.5M | $-2.1M | $— | — |
| Q2 null | $5.4M | 63.3% | $9.2M | $-13.0M | $— | — |
| Q1 null | $6.8M | 57.5% | $9.4M | $-9.2M | $— | — |
| Q4 null | $7.6M | 72.2% | $11.7M | $-9.6M | $— | — |
| FY null | $27.0M | 49.1% | $-57.7M | $-42.7M | $— | — |
| Q3 null | $7.4M | 70.3% | $12.0M | $-12.3M | $— | — |
| Q2 null | $6.3M | 63.8% | $16.2M | $-13.6M | $— | — |
| Q1 null | $5.8M | 42.2% | $17.9M | $-7.2M | $— | — |
| Q4 2023 | $3.6M | 34.2% | $14.2M | $-14.3M | $-0.44 | — |